Company page

Polypeptide Group Ag

Polypeptide Group AG, trading under the ticker PPGN, is a public company based in Switzerland. With a market capitalization of approximately 1.63 billion Swiss francs, it operates in the biopharmaceutical sector, specializing in the development and manufacturing of peptide-based therapeutics. The company focuses on delivering innovative solutions to meet the needs of its clients in the pharmaceutical industry.